Insider Transactions in Q2 2023 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 18
2023
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+7.69%
|
$200,010
$30.0 P/Share
|